link: http://ift.tt/1jaUDvL
Hot And Trending...
Trending
- Ep. 282: Hurricanes Rain On Market's Parade: http://bit.ly/2f1E46a via @YouTube
- Malinvestment and the Austrian Business Cycle, as explained by Yogi Berra
- 2008 Was Just a Tremor; The Real Economic Earthquake Is Coming https://t.co/SQo6W8cDxA @SchiffGold
- People are not buying gold because they need a safe haven from a geopolitical events. http://bit.ly/2eZzPba
- #Macy's stock price is down over 40% in the past 3 months on weaker sales. This supports my forecast for a weak holiday shopping season.
- In Search of the True Cost of Industrial Meat | Civil Eats
- SRSrocco sees the potential for a 40-50 million ounce production decline in 2017. http://bit.ly/2z34sZf
- Ep. 281: Weak Jobs Report Doesn't Rain on Market Parade: http://bit.ly/2gyn0Z7 via @YouTube
- Austria Begins Gold Repatriation; Maybe You Should Too @SchiffGold https://t.co/eCm1hJ00cj
- How negative interest rates work?
Wednesday, September 23, 2015
CEO who raised price of drug by 5000%
I know everyone is hating on this guy, but here is my view on the whole thing. So yeah this guy may be a prick, but from purely an economic sense, what he did might not be so terrible. The patent that Turing Pharmaceuticals purchased is for Daraprim, and from what I know, the patent is actually expired, all he bought was the right to sell the branded drug. No one is producing it generically - yet. With the massive price hike surely some pharmaceutical companies will come in with generic versions of Daraprim and undercut Turing's prices and increase supply until there is competitive equilibrium. What do you think?